- Home
- YMAB vs INOD Comparison
YMAB vs INOD Comparison
Compare YMAB & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- INOD
- Stock Information
- Founded
- YMAB 2015
- INOD 1988
- Country
- YMAB United States
- INOD United States
- Employees
- YMAB N/A
- INOD N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- INOD EDP Services
- Sector
- YMAB Health Care
- INOD Technology
- Exchange
- YMAB Nasdaq
- INOD Nasdaq
- Market Cap
- YMAB 631.1M
- INOD 623.4M
- IPO Year
- YMAB 2018
- INOD 1993
- Fundamental
- Price
- YMAB $11.14
- INOD $36.75
- Analyst Decision
- YMAB Strong Buy
- INOD Strong Buy
- Analyst Count
- YMAB 8
- INOD 3
- Target Price
- YMAB $21.38
- INOD $32.67
- AVG Volume (30 Days)
- YMAB 268.9K
- INOD 1.5M
- Earning Date
- YMAB 11-08-2024
- INOD 11-07-2024
- Dividend Yield
- YMAB N/A
- INOD N/A
- EPS Growth
- YMAB N/A
- INOD N/A
- EPS
- YMAB N/A
- INOD 0.62
- Revenue
- YMAB $84,553,000.00
- INOD $137,393,000.00
- Revenue This Year
- YMAB $10.24
- INOD $61.58
- Revenue Next Year
- YMAB $20.21
- INOD $29.95
- P/E Ratio
- YMAB N/A
- INOD $59.14
- Revenue Growth
- YMAB N/A
- INOD 71.66
- 52 Week Low
- YMAB $5.17
- INOD $5.46
- 52 Week High
- YMAB $20.90
- INOD $49.72
- Technical
- Relative Strength Index (RSI)
- YMAB 25.01
- INOD 66.87
- Support Level
- YMAB $12.47
- INOD $20.22
- Resistance Level
- YMAB $15.69
- INOD $49.72
- Average True Range (ATR)
- YMAB 0.97
- INOD 3.73
- MACD
- YMAB -0.46
- INOD 1.50
- Stochastic Oscillator
- YMAB 9.88
- INOD 56.81
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About INOD Innodata Inc.
Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.